Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas.
Balkan Med J. 2016 Sep;33(5):517-524. doi: 10.5152/balkanmedj.2016.151268. Epub 2016 Sep 1.
Balkan Med J. 2016.
PMID: 27761279
Free PMC article.
Skeletal muscle loss during anti-epidermal growth factor receptor therapy is an independent prognostic factor on non-small cell lung cancer patients survival.
Kucukarda A, Gokyer A, Gokmen I, Bekir Hacioglu M, Kostek O, Kurt N, Karabulut D, Tuncbilek N, Uzunoglu S, Erdogan B, Cicin I.
Kucukarda A, et al. Among authors: bekir hacioglu m.
J BUON. 2021 May-Jun;26(3):853-860.
J BUON. 2021.
PMID: 34268945
Free article.
Item in Clipboard
Is early change in systemic inflammatory markers associated with treatment response in patients who received pazopanib?
Erdogan B, Kostek O, Bekir Hacioglu M, Gokyer A, Kucukarda A, Ozcan E, Gokmen I, Uzunoglu S, Cicin I.
Erdogan B, et al. Among authors: bekir hacioglu m.
J BUON. 2021 Sep-Oct;26(5):2196-2201.
J BUON. 2021.
PMID: 34761635
Free article.
Item in Clipboard
Real-life data on first-line Sunitinib and Pazopanib therapy in metastatic renal cell carcinoma patients: a single center experience.
Topal A, Sayın S, Gokyer A, Kucukarda A, Kostek O, Bekir Hacıoglu M, Uzunoglu S, Erdogan B, Cicin I.
Topal A, et al. Among authors: bekir hacioglu m.
J BUON. 2021 Jul-Aug;26(4):1628-1634.
J BUON. 2021.
PMID: 34565028
Free article.
Item in Clipboard
Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey.
Bekir Hacioglu M, Kostek O, Karabulut S, Tastekin D, Sezgin Goksu S, Alandag C, Akagunduz B, Bilgetekin I, Caner B, Bilgehan Sahin A, Yildiz B, Kose F, Kaplan MA, Gulmez A, Dogan E, Can Guven D, Gurbuz M, Ergun Y, Karaagac M, Gokcen Demiray A, Turker S, Sakalar T, Ozkul O, Telli TA, Sahin S, Kilickap S, Bilici A, Erdogan B, Cicin I.
Bekir Hacioglu M, et al.
J BUON. 2020 Jul-Aug;25(4):1897-1903.
J BUON. 2020.
PMID: 33099930
Free article.
Item in Clipboard
Comparison of skeletal muscle mass loss in patients with metastatic colorectal cancer treated with regorafenib or TAS-102.
Bekir Hacioglu M, Kostek O, Kurt N, Kucukarda A, Gokyer A, Ustabasioglu FE, Karatas F, Tuncbilek N, Uzunoglu S, Bilici A, Cicin I, Erdogan B.
Bekir Hacioglu M, et al.
J BUON. 2019 Sep-Oct;24(5):2198-2204.
J BUON. 2019.
PMID: 31786894
Free article.
Item in Clipboard
Value of MRI apparent diffusion coefficient for assessment of response to sorafenib in hepatocellular carcinoma.
Kostek O, Yilmaz E, Bekir Hacıoglu M, Erdogan B, Kodaz H, Turkmen Bekmez E, Hacibekiroglu I, Uzunoglu S, Tuncbilek N, Cicin I.
Kostek O, et al. Among authors: bekir hacioglu m.
J BUON. 2018 Jul-Aug;23(4):979-984.
J BUON. 2018.
PMID: 30358202
Free article.
Item in Clipboard
Extremely high level of CA 19-9 in a patient with metastatic pancreatic cancer and chronic renal failure- Second highest level of CA 19-9 in the literature.
Aytekin A, Sahin S, Bekir Hacioglu M, Karatas F, Ince M.
Aytekin A, et al. Among authors: bekir hacioglu m.
J BUON. 2015 Jul-Aug;20(4):1169-70.
J BUON. 2015.
PMID: 26416073
Free article.
No abstract available.
Item in Clipboard
Cite
Cite